WealthTrust Fairport’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

WealthTrust Fairport’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-685	Closed	-$2K	–	561
2018 Q3	$2K	Hold	685	–	–	﹤0.01%	475
2018 Q2	$3K	Hold	685	–	–	﹤0.01%	453
2018 Q1	$3K	Buy	+685	New	+$3.19K	﹤0.01%	452
2015 Q1	–	Sell	-685	Closed	-$10K	–	434
2014 Q4	$10K	Hold	685	–	–	﹤0.01%	341
2014 Q3	$9K	Hold	685	–	–	﹤0.01%	265
2014 Q2	$11K	Buy	+685	New	+$9.71K	﹤0.01%	230

WealthTrust Fairport's KERX Position: Q4 2018 in Review

WealthTrust Fairport sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 685 shares — an estimated $2K sold.

WealthTrust Fairport first reported a position in KERX in Q2 2014 and held it in 6 quarters. The position peaked at $11K in Q2 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

WealthTrust Fairport reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
WealthTrust Fairport sold 685 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $2K.
WealthTrust Fairport first reported a position in Keryx Biopharmaceuticals Inc in Q2 2014 and held it in 6 quarters.
WealthTrust Fairport's Keryx Biopharmaceuticals Inc position peaked at $11K in Q2 2014.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on WealthTrust Fairport's 13F filing for Q4 2018, filed 25 Feb 2019.